Robbie Marcus

Q: What is Robbie Marcus's success rate?

Robbie Marcus currently has a success rate of 97.25187233079166.

Q: What is the average return of Robbie Marcus's calls?

Their stock ratings have generated an average return of 22.477318202995512.

JP Morgan | Healthcare

Robbie Marcus is an analyst from JP Morgan specializing in the Healthcare sector. Ranked #660 out of 4752 analysts, they have issued 36 stock ratings with a success rate of 97.25% and an average return of 22.48%.

Robbie Marcus has a well-established track record, with 36 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 97.25% and an average return of 22.48%, underscoring their expertise and ability to identify winning opportunities for investors.

#660

Out of 4752

Total Ratings

+97.25%

Success Rate

+22.48%

Average Return

Recent Ratings Analysis

PODD

Hold

Aug 06, 2026

Target

$152.00

Current

$139.30

Performance

0.00%

Robbie Marcus rated PODD as Neutral on Aug 06, 2026, setting a price target of 152. The Hold stance appears justified, as shares hovered around 139.3 with a 0.00% move.

INSP

Hold

Aug 04, 2026

Target

$60.00

Current

$58.89

Performance

-8.19%

On Aug 04, 2026, INSP was given a Neutral rating by Robbie Marcus, with a target price of 60. The rating provided protection from downside risk as the stock fell to 58.89.

SYK

Buy

Jul 31, 2026

Target

$350.00

Current

$337.43

Performance

3.60%

SYK received a Overweight rating from Robbie Marcus on Jul 31, 2026, aiming for 350. Price action was muted, as shares hovered around 337.43 despite the bullish outlook.

MMSI

Buy

Jul 31, 2026

Target

$95.00

Current

$87.69

Performance

3.15%

On Jul 31, 2026, Robbie Marcus published a Overweight outlook on MMSI, with a target of 95. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 87.69.

DXCM

Hold

Jul 31, 2026

Target

$82.00

Current

$83.02

Performance

-0.52%

Robbie Marcus on Jul 31, 2026 assigned DXCM a Neutral rating, with a price target of 82. The Hold stance reflected consolidation, as shares held near 83.02.

EW

Buy

Jul 24, 2026

Target

$105.00

Current

$89.32

Performance

8.10%

On Jul 24, 2026, Robbie Marcus reaffirmed EW with a Overweight rating, targeting 105. The recommendation was supported by strong follow-through as the stock rose from 89.32 to 89.32.

ISRG

Buy

Jul 17, 2026

Target

$450.00

Current

$373.71

Performance

8.19%

ISRG was rated Overweight by Robbie Marcus on Jul 17, 2026, with a price objective of 450. A bullish response from the market helped close the gap of 76.29 to the target.

ABT

Buy

Jul 17, 2026

Target

$120.00

Current

$107.95

Performance

7.22%

On Jul 17, 2026, Robbie Marcus initiated coverage on ABT with a Overweight rating and target of 120. The stock’s climb of 7.22% since the call highlights the foresight in the rating.

COO

Hold

Jun 05, 2026

Target

$71.00

Current

$73.32

Performance

8.88%

Robbie Marcus issued a Neutral recommendation for COO on Jun 05, 2026, price target set at 71. A neutral call gave way to stronger-than-expected performance, closing in on 71.

MOBI

Buy

Jun 02, 2026

Target

$15.00

Current

$12.32

Performance

—

On Jun 02, 2026, MOBI was evaluated by Robbie Marcus, who gave a Overweight rating and target of 15. So far, the Buy call awaits clearer momentum, with shares flat at 12.32.

CNMD

Hold

Apr 30, 2026

Target

$40.00

Current

$49.77

Performance

35.76%

Robbie Marcus rated CNMD as Neutral on Apr 30, 2026, setting a price target of 40. Despite the Hold call, shares climbed 35.76% to 49.77, revealing unexpected momentum.

GEHC

Hold

Apr 30, 2026

Target

$65.00

Current

$70.31

Performance

15.57%

On Apr 30, 2026, GEHC was given a Neutral rating by Robbie Marcus, with a target price of 65. The stock rallied from 70.31 to 70.31 after the Hold rating, surprising to the upside.

ZBH

Hold

Apr 29, 2026

Target

$95.00

Current

$97.19

Performance

21.38%

ZBH received a Neutral rating from Robbie Marcus on Apr 29, 2026, aiming for 95. Investors saw gains of 21.38% that the cautious stance didn’t fully capture.

HTFL

Buy

Mar 19, 2026

Target

$35.00

Current

$27.19

Performance

5.02%

On Mar 19, 2026, Robbie Marcus published a Overweight outlook on HTFL, with a target of 35. Shares gained 5.02%, underscoring the accuracy of the bullish outlook toward 35.

MDT

Hold

Feb 18, 2026

Target

$105.00

Current

$85.92

Performance

-12.76%

Robbie Marcus on Feb 18, 2026 assigned MDT a Neutral rating, with a price target of 105. The call successfully avoided chasing as shares lost 12.76%.

BSX

Buy

Feb 05, 2026

Target

$100.00

Current

$49.30

Performance

-36.50%

On Feb 05, 2026, Robbie Marcus reaffirmed BSX with a Overweight rating, targeting 100. Shares slid 36.50% despite the recommendation, highlighting downside risks.

RXST

Sell

Nov 06, 2025

Target

$9.00

Current

$6.08

Performance

-29.38%

RXST was rated Underweight by Robbie Marcus on Nov 06, 2025, with a price objective of 9. The Sell stance proved too pessimistic given the -29.38% climb.

CBLL

Buy

Nov 05, 2025

Target

$17.00

Current

$18.25

Performance

54.92%

On Nov 05, 2025, Robbie Marcus initiated coverage on CBLL with a Overweight rating and target of 17. The stock’s climb of 54.92% since the call highlights the foresight in the rating.

IART

Sell

Oct 31, 2025

Target

$13.00

Current

$17.10

Performance

42.38%

Robbie Marcus issued a Underweight recommendation for IART on Oct 31, 2025, price target set at 13. The bearish outlook played out, as shares fell from 17.1 to 17.1.

BLCO

Hold

Oct 30, 2025

Target

$16.00

Current

$16.35

Performance

7.99%

On Oct 30, 2025, BLCO was evaluated by Robbie Marcus, who gave a Neutral rating and target of 16. Investors who stayed in despite the Hold saw upside of 7.99%.

BAX

Hold

Feb 21, 2025

Target

$36.00

Current

$27.01

Performance

-20.14%

Robbie Marcus rated BAX as Neutral on Feb 21, 2025, setting a price target of 36. The cautious Hold call aligned with subsequent weakness, as shares slipped 20.14%.

BVS

Hold

Dec 17, 2024

Target

$13.00

Current

$13.98

Performance

25.38%

On Dec 17, 2024, BVS was given a Neutral rating by Robbie Marcus, with a target price of 13. The stock rallied from 13.98 to 13.98 after the Hold rating, surprising to the upside.

NPCE

Buy

Dec 17, 2024

Target

$14.00

Current

$13.90

Performance

20.66%

NPCE received a Overweight rating from Robbie Marcus on Dec 17, 2024, aiming for 14. Momentum has favored the Buy call, with shares climbing from 13.9 to 13.9, rewarding those who trusted the recommendation.

ATRC

Buy

Jul 31, 2024

Target

$30.00

Current

$39.49

Performance

83.08%

On Jul 31, 2024, Robbie Marcus published a Overweight outlook on ATRC, with a target of 30. Shares gained 83.08%, underscoring the accuracy of the bullish outlook toward 30.

TMCI

Hold

May 08, 2024

Target

$8.00

Current

$4.38

Performance

5.04%

Robbie Marcus on May 08, 2024 assigned TMCI a Neutral rating, with a price target of 8. Shares outperformed expectations, climbing 5.04% despite the neutral view.

SILK

Hold

May 01, 2024

Target

$21.00

Current

$27.49

Performance

36.36%

On May 01, 2024, Robbie Marcus reaffirmed SILK with a Neutral rating, targeting 21. Market strength beyond 27.49 went further than the conservative outlook suggested.

CVRX

Hold

May 01, 2024

Target

$13.00

Current

$5.94

Performance

-41.30%

CVRX was rated Neutral by Robbie Marcus on May 01, 2024, with a price objective of 13. Investors who stayed cautious avoided some of the 41.30% decline.

Frequency Asked Questions

Who is Robbie Marcus?

Robbie Marcus is an analyst from JP Morgan specializing in the Healthcare sector.

What is Robbie Marcus's success rate?

Robbie Marcus currently has a success rate of +97.25%.

How many ratings has Robbie Marcus issued?

Robbie Marcus has issued 36 stock ratings so far.

What is the average return of Robbie Marcus's calls?

Their stock ratings have generated an average return of +22.48%.

What is Robbie Marcus's ranking?

Robbie Marcus is ranked #660 out of 4752 analysts.

What types of ratings does Robbie Marcus give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Robbie Marcus?

You can follow Robbie Marcus by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Robbie Marcus?

Their latest rating was a Hold on PODD issued on 2026-08-06.